Personalis (PSNL) Stock Forecast, Price Target & Predictions


OverviewRevenueOwnershipFinancialsChartTranscripts

PSNL Stock Forecast


Personalis (PSNL) stock forecast, based on 10 Wall Street analysts, predicts a 12-month average price target of $7.75, with a high of $13.00 and a low of $4.00. This represents a 135.56% increase from the last price of $3.29.

- $3 $6 $9 $12 $15 High: $13 Avg: $7.75 Low: $4 Last Closed Price: $3.29

PSNL Stock Rating


Personalis stock's rating consensus is Buy, based on 10 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 10 Buy (100.00%), 0 Hold (0.00%), 0 Sell (0.00%), and 0 Strong Sell (0.00%).

Buy
Total 10 0 10 Strong Sell Sell Hold Buy Strong Buy

PSNL Price Target Upside V Benchmarks


TypeNameUpside
StockPersonalis135.56%
SectorHealthcare Stocks 33.91%
IndustryDiagnostics & Research Stocks45.48%

Price Target Trends


1M3M12M
# Anlaysts--7
Avg Price Target--$6.07
Last Closing Price$3.29$3.29$3.29
Upside/Downside--84.50%
Ratings Trends

DateStrong BuyBuyHoldSellStrong SellTotal
Apr, 25241--7
Mar, 25231--6
Feb, 25231--6
Jan, 25231--6
Dec, 24231--6
Analyst Price Target Forecasts

DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Aug 19, 2024Thomas FlatenLake Street$8.00$5.9135.36%143.16%
Aug 19, 2024Swayampakula RamakanthH.C. Wainwright$9.00$5.9950.25%173.56%
Aug 16, 2024Mark MassaroBTIG$7.00$5.9916.86%112.77%
Aug 08, 2024Mark MassaroBTIG$5.50$3.4360.35%67.17%
Aug 08, 2024Mike MatsonNeedham$5.50$2.8890.97%67.17%
Jun 21, 2024Mike MatsonNeedham$3.50$1.22186.89%6.38%
Apr 30, 2024Thomas FlatenLoop Capital Markets$4.00$1.47172.11%21.58%
May 06, 2022Morgan Stanley$13.00$5.16151.94%295.14%
Analyst Rating Forecasts

DateCompanyPrevious RatingNew RatingRating Change
Jan 08, 2025Lake StreetBuyBuyhold
Dec 20, 2024BTIGBuyBuyhold
Aug 19, 2024Lake StreetBuyBuyhold
Aug 19, 2024BTIGUnderperformUnderperformhold
Aug 19, 2024H.C. WainwrightBuyBuyhold
Aug 08, 2024BTIGBuyBuyhold
Aug 08, 2024NeedhamBuyBuyhold
Jun 21, 2024NeedhamBuyBuyhold
May 09, 2024NeedhamBuyBuyhold
Apr 30, 2024Lake StreetBuyinitialise

Financial Forecast


EPS Forecast

Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-1.06$-1.49$-2.48$-2.25$-1.37----
Avg Forecast$-1.13$-1.53$-2.45$-2.21$-1.45$-1.08$-0.89$-0.39$-0.05
High Forecast$-1.04$-1.41$-2.23$-2.11$-1.41$-0.99$-0.67$-0.36$-0.05
Low Forecast$-1.24$-1.68$-2.82$-2.31$-1.49$-1.15$-1.29$-0.41$-0.05
Surprise %-6.19%-2.61%1.22%1.81%-5.52%----

Revenue Forecast

$50M $100M $150M $200M $250M $300M Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$78.65M$85.49M$65.05M$73.48M-----
Avg Forecast$78.43M$85.32M$65.05M$73.42M$84.60M$84.66M$109.85M$179.78M$242.84M
High Forecast$84.34M$91.75M$72.44M$73.45M$85.26M$87.32M$109.85M$187.74M$253.60M
Low Forecast$73.56M$80.02M$60.39M$73.39M$83.94M$80.29M$109.85M$169.14M$228.47M
Surprise %0.27%0.20%0.00%0.09%-----

Net Income Forecast

$-150M $-120M $-90M $-60M $-30M $0 Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-41.28M$-65.23M$-113.31M$-108.30M$-81.28M----
Avg Forecast$-39.22M$-71.57M$-98.51M$-108.30M$-69.76M$-51.70M$-47.13M$-18.61M$-2.41M
High Forecast$-31.38M$-57.26M$-78.81M$-86.64M$-67.76M$-47.77M$-32.06M$-17.34M$-2.22M
Low Forecast$-47.06M$-85.89M$-118.22M$-129.96M$-71.75M$-55.64M$-62.20M$-19.87M$-2.55M
Surprise %5.25%-8.87%15.03%-16.52%----

PSNL Forecast FAQ


Is Personalis stock a buy?

Personalis stock has a consensus rating of Buy, based on 10 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 10 Buy, 0 Hold, 0 Sell, and 0 Strong Sell, reflecting a consensus that Personalis is a favorable investment for most analysts.

What is Personalis's price target?

Personalis's price target, set by 10 Wall Street analysts, averages $7.75 over the next 12 months. The price target range spans from $4 at the low end to $13 at the high end, suggesting a potential 135.56% change from the previous closing price of $3.29.

How does Personalis stock forecast compare to its benchmarks?

Personalis's stock forecast shows a 135.56% upside, outperforming the average forecast for the healthcare stocks sector (33.91%) and outperforming the diagnostics & research stocks industry (45.48%).

What is the breakdown of analyst ratings for Personalis over the past three months?

  • April 2025: 28.57% Strong Buy, 57.14% Buy, 14.29% Hold, 0% Sell, 0% Strong Sell.
  • March 2025: 33.33% Strong Buy, 50.00% Buy, 16.67% Hold, 0% Sell, 0% Strong Sell.
  • February 2025: 33.33% Strong Buy, 50.00% Buy, 16.67% Hold, 0% Sell, 0% Strong Sell.

What is Personalis’s EPS forecast?

Personalis's average annual EPS forecast for its fiscal year ending in December 2025 is $-1.08, marking a -21.17% decrease from the reported $-1.37 in 2024. Estimates for the following years are $-0.89 in 2026, $-0.39 in 2027, and $-0.05 in 2028.

What is Personalis’s revenue forecast?

Personalis's average annual revenue forecast for its fiscal year ending in December 2025 is $84.66M, reflecting a 0% decrease from the reported $0 in 2024. The forecast for 2026 is $109.85M, followed by $179.78M for 2027, and $242.84M for 2028.

What is Personalis’s net income forecast?

Personalis's net income forecast for the fiscal year ending in December 2025 stands at $-51.702M, representing a -36.39% decrease from the reported $-81.284M in 2024. Projections indicate $-47.128M in 2026, $-18.606M in 2027, and $-2.409M in 2028.